Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Concerta in adolescents with ADHD
NCT00249353Phase 3Completed
- Sponsor
- McNeil Laboratories
- Start
- Mar 2002
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of methylphenidate in attention deficit hyperactivity disorder (ADHD), sponsored by McNeil Laboratories. Started Mar 2002; status: completed.
02
Drugs
methylphenidate
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT00249353.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00249353.